Coronavirus updates

Moderna is trying to be the first to get its COVID-19 vaccine approved for children six months to six years old

Pfizer’s oral COVID-19 treatment nirmatrelvir is about to become more widely accessible.

South African drug manufacturer Aspen Pharmacare has signed a deal to manufacture and distribute Johnson & Johnson's COVID vax

Arbutus and Genevant are taking Moderna to court, claiming Moderna misused Arbutus’ patented technology to create a COVID-19 vaccine in “record time.”

Pfizer-BioNTech and Moderna are gathering data to determine if their coronavirus vaccines will work against the mutated version of the virus found in the United Kingdom and other...

Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) have green lighted the drugmakers' COVID-19...

The FDA’s Vaccines and Related Biological Products Advisory Committee has overwhelmingly supported the FDA granting Emergency Use Authorization for Moderna's COVID-19 mRNA vaccine...

The U.S. rollout of the first coronavirus vaccine began this morning as the first doses of Pfizer-BioNTech's BNT162b2 were administered to health care workers and nursing home...

Sanofi and GlaxoSmithKline have delayed advanced trials of their experimental adjuvanted recombinant protein-based COVID-19 vaccine after it failed to produce a strong enough ...

Pfizer and BioNTech have announced that the U.S. FDA's VRBPAC voted 17 to 4 in support of the FDA granting Emergency Use Authorization for the companies’ COVID-19 mRNA vaccine...

Researchers at the Institute for Biomedical Sciences at Georgia State University say that treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 (Molnupiravir...

Moderna is planning a clinical trial of its COVID-19 vaccine candidate, mRNA-1273, with children ages 12 through 17.

United Airlines began operating charter flights to position doses of Pfizer-BioNTech's COVID-19 vaccine for quick distribution if granted approval by regulators, according to ...

Pfizer and BioNTech announced that they have submitted a request to the U.S. FDA for an Emergency Use Authorization of their COVID-19 vaccine candidate.